Significance of Pathologic T3a Upstaging in Clinical T1 Renal Masses Undergoing Nephrectomy

Krishna Ramaswamy, Emil Kheterpal, Hai Pham, Sanjay Mohan, Michael Stifelman, Samir Taneja, William C. Huang

    Research output: Contribution to journalArticle

    Abstract

    Background The objectives of the present study were to report the incidence of pathologic T3a upstaging in a contemporary cohort of patients with clinical stage T1 (cT1) renal tumors treated with partial or radical nephrectomy; investigate the clinical outcomes; and identify the predictors associated with pathologic upstaging. Materials and Methods From a single-institution, institutional review board-approved renal tumor database of 945 patients, we identified 610 patients who had undergone surgery for a cT1 renal mass. Data for 494 patients were available for analysis. Of these, 66 lesions had been pathologically upstaged to T3a after surgery and 428 had not. The oncologic follow-up data and clinical and pathologic features were recorded, and multivariable logistic regression analysis was performed to identify the risk factors for pT3a upstaging, controlling for age, gender, body mass index, and nephrectomy type. Results The cT1 tumors of 66 patients (13.3%) were upstaged to pT3a after surgery. Of these 66 patients, 44 (66.7%) had undergone partial and 22 (33.3%) radical nephrectomy. The median follow-up period was 50 months. No patient with upstaging developed recurrence, and all were disease free at their last follow-up visit. On multivariable analysis, tumor size > 4 cm (odds ratio [OR], 3.766; 95% confidence interval [CI], 1.417-10.011; P <.008), clear cell histologic features (OR, 4.461; 95% CI, 1.498-13.461; P <.007), and positive surgical margins (hazard ratio, 5.118; 95% CI, 2.088-12.547; P <.0001) were associated with upstaging. Conclusion Of the cT1 lesions in 66 patients, 13% were pathologically upstaged after surgery. The patients with larger tumors, clear cell histologic features, and positive surgical margins were at the greatest risk of upstaging. However, after an intermediate follow-up period, pathologic upstaging did not appear to result in worsened oncologic outcomes.

    Original languageEnglish (US)
    Pages (from-to)344-349
    Number of pages6
    JournalClinical Genitourinary Cancer
    Volume13
    Issue number4
    DOIs
    StatePublished - Aug 1 2015

    Keywords

    • Adverse features
    • Kidney cancer
    • Renal cell carcinoma
    • Risk
    • Surveillance

    ASJC Scopus subject areas

    • Oncology
    • Urology

    Fingerprint Dive into the research topics of 'Significance of Pathologic T3a Upstaging in Clinical T1 Renal Masses Undergoing Nephrectomy'. Together they form a unique fingerprint.

  • Cite this

    Ramaswamy, K., Kheterpal, E., Pham, H., Mohan, S., Stifelman, M., Taneja, S., & Huang, W. C. (2015). Significance of Pathologic T3a Upstaging in Clinical T1 Renal Masses Undergoing Nephrectomy. Clinical Genitourinary Cancer, 13(4), 344-349. https://doi.org/10.1016/j.clgc.2015.01.001